Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
120.38
-1.17 (-0.96%)
Aug 11, 2026, 10:38 AM EDT - Market open
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Product Revenues | 4.97B | 4.54B | 4.35B | 4.15B | 3.96B | 3.81B | 3.62B | 3.46B | ||||||||||||||||||||||||
| Net Product Revenues Growth | 25.26% | 19.03% | 20.32% | 19.93% | 20.80% | 19.03% | 14.33% | 12.83% | ||||||||||||||||||||||||
| Royalties | 681.05M | 657.48M | 636.91M | 612.15M | 597.91M | 583.99M | 579.36M | 569.68M | ||||||||||||||||||||||||
| Royalties Growth | 13.91% | 12.58% | 9.93% | 7.46% | 9.98% | 9.35% | 10.67% | 12.51% | ||||||||||||||||||||||||
| Milestone and Contracts | 173.20M | 167.00M | 150.00M | 50.00M | 23.00M | 18.00M | 20.50M | 22.50M | ||||||||||||||||||||||||
| Milestone and Contracts Growth | 653.04% | 827.78% | 631.71% | 122.22% | 142.11% | 89.47% | 192.86% | -35.71% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and Development | 2.15B | 2.13B | 2.05B | 1.90B | 1.97B | 2.61B | 2.61B | 2.59B | ||||||||||||||||||||||||
| Research and Development Growth | 9.10% | -18.59% | -21.36% | -26.32% | -17.44% | 58.46% | 60.17% | 53.48% | ||||||||||||||||||||||||
| Selling, General, and Administrative | 1.40B | 1.38B | 1.38B | 1.31B | 1.29B | 1.27B | 1.24B | 1.21B | ||||||||||||||||||||||||
| Selling, General, and Administrative Growth | 8.25% | 8.76% | 10.79% | 8.53% | 10.67% | 10.62% | 6.96% | 6.06% | ||||||||||||||||||||||||
| Loss Under Collaboration Agreements | - | - | - | - | - | - | -1.03M | 1.88M | ||||||||||||||||||||||||
| Loss on Change in Fair Value of Acquisition-Related Contingent Consideration | -38.13M | -17.87M | -6.13M | 18.09M | 53.70M | 31.83M | 19.80M | 38.91M | ||||||||||||||||||||||||
| Loss on Change in Fair Value of Acquisition-Related Contingent Consideration Growth | - | - | - | -53.51% | 256.35% | 41.16% | -32.19% | 1.08% |